Mark Sculpher : Citation Profile


Are you Mark Sculpher?

15

H index

20

i10 index

946

Citations

RESEARCH PRODUCTION:

29

Articles

18

Papers

2

Books

2

Chapters

RESEARCH ACTIVITY:

   23 years (1995 - 2018). See details.
   Cites by year: 41
   Journals where Mark Sculpher has often published
   Relations with other researchers
   Recent citing documents: 89.    Total self citations: 23 (2.37 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/psc810
   Updated: 2022-08-13    RAS profile: 2018-10-25    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Claxton, Karl (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Mark Sculpher.

Is cited by:

Brouwer, Werner (35)

Claxton, Karl (27)

Walker, Simon (22)

Asaria, Miqdad (13)

Culyer, Anthony (10)

van Exel, Job (10)

EPSTEIN, DAVID (9)

Revill, Paul (8)

Devlin, Nancy (8)

Russell, Louise (8)

Brazier, John (7)

Cites to:

Claxton, Karl (62)

Culyer, Anthony (19)

Brouwer, Werner (17)

Johannesson, Magnus (16)

Rice, Nigel (14)

Walker, Simon (10)

Mullahy, John (10)

McCabe, Christopher (10)

Devlin, Nancy (7)

Martin, Stephen (7)

Parkin, David (6)

Main data


Where Mark Sculpher has published?


Journals with more than one article published# docs
Health Economics16
PharmacoEconomics8
The European Journal of Health Economics2

Working Papers Series with more than one paper published# docs
Working Papers / Centre for Health Economics, University of York13
Centre for Health Economics and Policy Analysis Working Paper Series / Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada3

Recent works citing Mark Sculpher (2022 and 2021)


YearTitle of citing document
2021Paying for health gains. (2021). Chalkley, Martin ; Gravelle, Hugh ; Gutacker, Nils ; Gaughan, James ; Siciliani, Luigi. In: Working Papers. RePEc:chy:respap:183cherp.

Full description at Econpapers || Download paper

2021Robustness of cost-effectiveness analyses of cluster randomized trials assuming bivariate normality against skewed cost data. (2021). , Gerard ; Manju, Md Abu. In: Computational Statistics & Data Analysis. RePEc:eee:csdana:v:157:y:2021:i:c:s0167947320302346.

Full description at Econpapers || Download paper

2021Toward collaborative cost-inclusive evaluation: Adaptations and transformations for evaluators and economists. (2021). Yates, Brian T. In: Evaluation and Program Planning. RePEc:eee:epplan:v:89:y:2021:i:c:s0149718921000884.

Full description at Econpapers || Download paper

2021Cancer care at home or in local health centres versus in hospital: Public policy goals and patients’ preferences in the Rhône-Alps region in France. (2021). Margier, Jennifer ; Moumjid, Nora ; Gafni, Amiram. In: Health Policy. RePEc:eee:hepoli:v:125:y:2021:i:2:p:213-220.

Full description at Econpapers || Download paper

2021Taking a local government perspective for economic evaluation of a population-level programme to promote exercise. (2021). Bojke, Laura ; Hill, Andrew J ; Meads, David ; Candio, Paolo. In: Health Policy. RePEc:eee:hepoli:v:125:y:2021:i:5:p:651-657.

Full description at Econpapers || Download paper

2021Evaluations of public health interventions produced by health technology assessment agencies: A mapping review and analysis by type and evidence content. (2021). Gopinathan, Unni ; Ottersen, Trygve ; Chalkidou, Kalipso ; Jain, Vageesh ; Cyr, Pascale Renee. In: Health Policy. RePEc:eee:hepoli:v:125:y:2021:i:8:p:1054-1064.

Full description at Econpapers || Download paper

2021Economic evaluation of nutrition interventions: Does one size fit all?. (2021). Mazzocchi, Mario ; Shankar, Bhavani ; Hutton, Zsuzsa V ; Detzel, Patrick ; Drummond, Michael ; Federici, Carlo ; Fattore, Giovanni. In: Health Policy. RePEc:eee:hepoli:v:125:y:2021:i:9:p:1238-1246.

Full description at Econpapers || Download paper

2022Cost-effectiveness of home-based stroke rehabilitation across Europe: A modelling study. (2022). Leal, Jose ; Luengo-Fernandez, Ramon ; Violato, Mara ; Candio, Paolo. In: Health Policy. RePEc:eee:hepoli:v:126:y:2022:i:3:p:183-189.

Full description at Econpapers || Download paper

2022A Markov model examining intervention effects on the HIV prevalence/incidence amongst the overall population. (2022). Nagi, Rakesh ; Ghayoori, Arash. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:79:y:2022:i:c:s0038012121001154.

Full description at Econpapers || Download paper

2021Cost-effectiveness analysis of housing first intervention with an independent housing and team support for homeless people with severe mental illness: A Markov model informed by a randomized controlle. (2021). Auquier, Pascal ; Tinland, Aurelie ; Girard, Vincent ; Boucekine, Mohamed ; Loubiere, Sandrine ; Lemoine, Coralie. In: Social Science & Medicine. RePEc:eee:socmed:v:272:y:2021:i:c:s0277953621000241.

Full description at Econpapers || Download paper

2021Eliciting a monetary threshold for a year of sufficient capability to inform resource allocation decisions in public health and social care. (2021). Afentou, Nafsika ; Kinghorn, Philip. In: Social Science & Medicine. RePEc:eee:socmed:v:279:y:2021:i:c:s0277953621003099.

Full description at Econpapers || Download paper

2021Providing universal access to modern contraceptive methods: An extended cost-effectiveness analysis of meeting the demand for modern contraception in Ethiopia. (2021). Norheim, O F ; Tolla, M T ; Enden, M R. In: Social Science & Medicine. RePEc:eee:socmed:v:281:y:2021:i:c:s0277953621004081.

Full description at Econpapers || Download paper

2021Modelling the economic impact of reducing loneliness in community dwelling older people in england. (2021). A-La Park, ; McDaid, David. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:108594.

Full description at Econpapers || Download paper

2022National Investment Framework for Revitalizing the R&D Collaborative Ecosystem of Sustainable Smart Agriculture. (2022). Kim, Keunhwan ; Lee, Doyeon. In: Sustainability. RePEc:gam:jsusta:v:14:y:2022:i:11:p:6452-:d:823937.

Full description at Econpapers || Download paper

2021Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution. (2021). Duval, Laetitia ; Kamate, Beh ; Diawara, Fatou ; Steinhardt, Laura ; Conteh, Lesong ; Cairns, Matt ; Dicko, Alassane ; Walker, Patrick ; Eckert, Erin ; Mihigo, Jules ; Sadou, Aboubacar ; Sagara, Issaka ; Sicuri, Elisa. In: Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers). RePEc:hal:cesptp:hal-03184961.

Full description at Econpapers || Download paper

2021Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). (2021). Bousmah, Marwân-al-Qays ; Maradan, Gwenaelle ; Mpoudi-Etame, Mireille ; Wandji, Martial Lantche ; Tovar-Sanchez, Tamara ; Nishimwe, Marie ; Boyer, Sylvie ; Marwan-Al-Qays Bousmah, ; Delaporte, Eric ; Kouanfack, Charles ; Montoyo, Alice ; Varloteaux, Marie ; Bassega, Pierrette Omgba. In: Post-Print. RePEc:hal:journl:hal-03174666.

Full description at Econpapers || Download paper

2021Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution. (2021). Duval, Laetitia ; Kamate, Beh ; Diawara, Fatou ; Steinhardt, Laura ; Conteh, Lesong ; Cairns, Matt ; Dicko, Alassane ; Walker, Patrick ; Eckert, Erin ; Mihigo, Jules ; Sadou, Aboubacar ; Sagara, Issaka ; Sicuri, Elisa. In: Post-Print. RePEc:hal:journl:hal-03184961.

Full description at Econpapers || Download paper

2022Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in Fr. (2022). van Steen, Cecile ; Lazzaro, Carlo ; Angelillo, Luigi ; Schweitzer, Cedric ; Aptel, Florent. In: Post-Print. RePEc:hal:journl:hal-03696350.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021The Economic Costs of Child Maltreatment in UK. (2021). Melnychuk, Mariya ; Morris, Stephen ; Pizzo, Elena ; Conti, Gabriella. In: IZA Discussion Papers. RePEc:iza:izadps:dp14612.

Full description at Econpapers || Download paper

2021Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa. (2021). Reddy, Krishna P ; Siedner, Mark J ; Freedberg, Kenneth A ; Shebl, Fatma M ; Panella, Christopher ; Lessells, Richard J ; Harling, Guy ; Scott, Justine A ; Fitzmaurice, Kieran P. In: Nature Communications. RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-26557-5.

Full description at Econpapers || Download paper

2021Cost-effectiveness in health: consolidated research and contemporary challenges. (2021). Santos, Eric Kaun ; Silva, Eduardo Damio ; Marques, Sandro ; Moraes, Thyago Proena ; Viegas, Maria Alexandra ; Westarb, June Alisson. In: Palgrave Communications. RePEc:pal:palcom:v:8:y:2021:i:1:d:10.1057_s41599-021-00940-5.

Full description at Econpapers || Download paper

2021Cost-effectiveness analysis of domiciliary topical sevoflurane for painful leg ulcers. (2021). Geronimo-Pardo, Manuel ; Cortias-Saenz, Manuel ; Fernandez-Gines, Damaso F ; Selva-Sevilla, Carmen. In: PLOS ONE. RePEc:plo:pone00:0257494.

Full description at Econpapers || Download paper

2022Approaches to Estimating Indirect Costs in Healthcare: Motivations for Choice. (2022). Mennini, Francesco Saverio ; Gitto, Lara. In: MPRA Paper. RePEc:pra:mprapa:112129.

Full description at Econpapers || Download paper

2021Spillover Effects of Retirement: does health vulnerability matter?. (2021). Tang, Kam Ki ; Yazbeck, Myra ; Ki, Kam ; Kwak, Do Won ; Byrne, Dominic . In: Discussion Papers Series. RePEc:qld:uq2004:643.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021Uncertainty Analysis in Intervention Impact on Health Inequality for Resource Allocation Decisions. (2021). Walker, Simon ; Griffin, Susan ; Duarte, Ana ; Yang, Fan. In: Medical Decision Making. RePEc:sae:medema:v:41:y:2021:i:6:p:653-666.

Full description at Econpapers || Download paper

2022Simulating Study Data to Support Expected Value of Sample Information Calculations: A Tutorial. (2022). Goldhaber-Fiebert, Jeremy D ; Welton, Nicky J ; Kunst, Natalia ; Glynn, David ; Strong, Mark ; Heath, Anna. In: Medical Decision Making. RePEc:sae:medema:v:42:y:2022:i:2:p:143-155.

Full description at Econpapers || Download paper

2022Multilevel and Quasi Monte Carlo Methods for the Calculation of the Expected Value of Partial Perfect Information. (2022). Thom, Howard ; Andrieu, Christophe ; Welton, Nicky J ; Jackson, Chris H ; Giles, Michael B ; Wang, Zhenru ; Fang, Wei. In: Medical Decision Making. RePEc:sae:medema:v:42:y:2022:i:2:p:168-181.

Full description at Econpapers || Download paper

2022Reference Case Methods for Expert Elicitation in Health Care Decision Making. (2022). Taylor, Andrea ; Sharples, Linda D ; Morton, Alec ; Jankovic, Dina ; Jackson, Chris ; Fox, Aime ; Colson, Abigail ; Claxton, Karl ; Soares, Marta O ; Bojke, Laura. In: Medical Decision Making. RePEc:sae:medema:v:42:y:2022:i:2:p:182-193.

Full description at Econpapers || Download paper

2022Development and Validation of a Discrete Event Simulation Model to Evaluate the Cardiovascular Impact of Population Policies for Obesity. (2022). Mar, Javier ; Larraaga, Igor ; Castilla, Ivn ; Ibarrondo, Oliver ; Arrospide, Arantzazu. In: Medical Decision Making. RePEc:sae:medema:v:42:y:2022:i:2:p:241-254.

Full description at Econpapers || Download paper

2022Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Chal. (2022). Schramm, Wendelin ; Heathcote, Laura ; Clarke, Philip ; Sailer, Fabian ; Herman, William H ; Gray, Alastair ; Gahn, James ; Ramos, Mafalda ; Brennan, Alan ; Ye, Wen ; Pollard, Daniel ; Asseburg, Christian ; Yu, Xueting ; Patel, Rishi ; Yang, Chunting ; Tew, Michelle ; Palmer, Andrew J ; Feenstra, Talitha ; Willis, Michael ; Nilsson, Andreas ; Tran-Duy, AN ; Smolen, Harry J ; McEwan, Phil ; Isaman, Deanna ; Si, Lei ; Lamotte, Mark ; Bennett, Hayley ; Shi, Lizheng ; Kuo, Shihchen ; Zhang, Ping ; Shao, Hui ; Thomas, Chloe ; Leal, Jos. In: Medical Decision Making. RePEc:sae:medema:v:4
2022An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial. (2022). Welton, Nicky J ; Aas, Eline ; Wislff, Torbjrn ; Strong, Mark ; Vervaart, Mathyn ; Claxton, Karl P. In: Medical Decision Making. RePEc:sae:medema:v:42:y:2022:i:5:p:612-625.

Full description at Econpapers || Download paper

2022Calculating Expected Value of Sample Information Adjusting for Imperfect Implementation. (2022). Heath, Anna. In: Medical Decision Making. RePEc:sae:medema:v:42:y:2022:i:5:p:626-636.

Full description at Econpapers || Download paper

2022Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity. (2022). Heath, Anna ; Pechlivanoglou, Petros. In: Medical Decision Making. RePEc:sae:medema:v:42:y:2022:i:5:p:649-660.

Full description at Econpapers || Download paper

2022Estimating Value-Based Price and Quantifying Uncertainty around It in Health Technology Assessment: Frequentist and Bayesian Approaches. (2022). Shiroiwa, Takeru ; Hagiwara, Yasuhiro. In: Medical Decision Making. RePEc:sae:medema:v:42:y:2022:i:5:p:672-683.

Full description at Econpapers || Download paper

2021Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator. (2021). Hindricks, Gerhard ; Dagres, Nikolaos ; Elsner, Christian ; Eisemann, Nora ; Frielitz, Fabian-Simon ; Hadwiger, Moritz ; Katalinic, Alexander. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:1:d:10.1007_s40258-020-00571-y.

Full description at Econpapers || Download paper

2021Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer. (2021). Muller, Dirk ; Stock, Stephanie ; Estevez, Maria Pilar ; Correa-Galendi, Julia Simoes. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:1:d:10.1007_s40258-020-00599-0.

Full description at Econpapers || Download paper

2021Systematic Review and Critique of Methods for Economic Evaluation of Digital Mental Health Interventions. (2021). Melton, Hollie ; Churchill, Rachel ; Goncalves, Pedro Saramago ; Marshall, David ; Bojke, Laura ; Jankovic, Dina ; Gega, Lina ; Brabyn, Sally. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:1:d:10.1007_s40258-020-00607-3.

Full description at Econpapers || Download paper

2021Is the Choice of Cost-Effectiveness Threshold in Cost-Utility Analysis Endogenous to the Resulting Value of Technology? A Systematic Review. (2021). Phelps, Charles E ; Chen, Hui-Han ; Padula, William V. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:2:d:10.1007_s40258-020-00606-4.

Full description at Econpapers || Download paper

2021Management of Chest Indrawing Pneumonia in Children Under Five Years at the Outpatient Health Facilities in Nigeria: An Economic Evaluation. (2021). Okafor, Charles E. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:3:d:10.1007_s40258-020-00627-z.

Full description at Econpapers || Download paper

2021Copula Models for Addressing Sample Selection in the Evaluation of Public Health Programmes: An Application to the Leeds Let’s Get Active Study. (2021). Pulkki-Brannstrom, Anni-Maria ; Gomes, Manuel ; Poupakis, Stavros ; Bojke, Chris ; Hill, Andrew J ; Candio, Paolo. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:3:d:10.1007_s40258-020-00629-x.

Full description at Econpapers || Download paper

2021Cost-Effectiveness and Value of Information of Cabozantinib Treatment for Patients with Advanced Renal Cell Carcinoma After Failure of Prior Therapy in South Korea. (2021). Suh, Hae Sun ; Kim, Hyung Tae ; Han, Sola. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:4:d:10.1007_s40258-021-00640-w.

Full description at Econpapers || Download paper

2021A Review of Web-Based Tools for Value-of-Information Analysis. (2021). Rothery, Claire ; Tuffaha, Haitham ; Birch, Stephen ; Strong, Mark ; Jackson, Chris ; Kunst, Natalia. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:5:d:10.1007_s40258-021-00662-4.

Full description at Econpapers || Download paper

2021How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13. (2021). Martin, Stephen ; Longo, Francesco ; Claxton, Karl ; Lomas, James. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:6:d:10.1007_s40258-021-00663-3.

Full description at Econpapers || Download paper

2021Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models. (2021). , Edward. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:6:d:10.1007_s40258-021-00664-2.

Full description at Econpapers || Download paper

2022Economic Evaluation of an Intervention Designed to Reduce Bullying in Australian Schools. (2022). Brain, David ; Cheng, Qinglu ; Scott, James G ; Thomas, Hannah J ; Pacella, Rosana ; Cross, Donna ; Graves, Nicholas ; Jadambaa, Amarzaya. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00676-y.

Full description at Econpapers || Download paper

2022Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis. (2022). Mennini, Francesco Saverio ; Kondili, Loreta A ; Simonelli, Claudia ; Marcellusi, Andrea. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00677-x.

Full description at Econpapers || Download paper

2022Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment. (2022). Faria, Rita ; Ochalek, Jessica ; Lomas, James. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00679-9.

Full description at Econpapers || Download paper

2022From Spreadsheets to Script: Experiences From Converting a Scottish Cardiovascular Disease Policy Model into R. (2022). Lewsey, Jim ; Lawson, Kenny D ; McAllister, David A ; Briggs, Andrew ; Kohli-Lynch, Ciaran ; Heggie, Robert ; Haghpanahan, Houra ; Robles-Zurita, Jose Antonio ; Gray, Ewan ; Xin, Yiqiao. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:2:d:10.1007_s40258-021-00684-y.

Full description at Econpapers || Download paper

2022Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?. (2022). Thom, Howard. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:3:d:10.1007_s40258-021-00700-1.

Full description at Econpapers || Download paper

2022Cost-effectiveness Analysis of the Dental RECUR Pragmatic Randomized Controlled Trial: Evaluating a Goal-oriented Talking Intervention to Prevent Reoccurrence of Dental Caries in Children. (2022). Cynthia, Pine M ; Pauline, Adair ; Girvan, Burnside ; Rhiannon, Edwards T ; Victory, Ezeofor. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:3:d:10.1007_s40258-022-00720-5.

Full description at Econpapers || Download paper

2021Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses. (2021). Ramos-Goi, Juan M ; Estevez-Carrillo, Anabel ; Silvan, Carlos Vila ; Ortin-Sulbaran, Daniela ; Oppe, Mark. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:5:d:10.1007_s10198-021-01285-1.

Full description at Econpapers || Download paper

2021Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands. (2021). Pol, Simon ; Postma, Maarten J ; Boersma, Cornelis ; Schans, Simon ; Hagendijk, Marije E. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:6:d:10.1007_s10198-021-01303-2.

Full description at Econpapers || Download paper

2022HIT-6 and EQ-5D-5L in patients with migraine: assessment of common latent constructs and development of a mapping algorithm. (2022). Aigner, Annette ; Kurth, Tobias ; Neeb, Lars ; Panteli, Dimitra ; Oliveira, Ana Sofia. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:1:d:10.1007_s10198-021-01342-9.

Full description at Econpapers || Download paper

2022The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study. (2022). Loughnane, Gerard ; Ursul, Diana ; Sharp, Linda ; Ahern, Michelle ; Hanly, Paul. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:2:d:10.1007_s10198-021-01351-8.

Full description at Econpapers || Download paper

2022Economic evaluation of a complex intervention (Engager) for prisoners with common mental health problems, near to and after release: a cost-utility and cost-consequences analysis. (2022). Taylor, Rod S ; Warren, Fiona ; Lennox, Charlotte ; Kirkpatrick, Tim ; Anderson, Rob ; Hunter, Rachael Maree ; Byng, Richard ; Maguire, Mike ; Stirzaker, Alex ; Haddad, Mark ; Shaw, Jenny . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:2:d:10.1007_s10198-021-01360-7.

Full description at Econpapers || Download 2021

Time-to-event analysis in economic evaluations: a comparison of modelling methods to assess the cost-effectiveness of transplanting a marginal quality kidney. (2021). Senanayake, Sameera ; Healy, Helen ; Baboolal, Keshwar ; Graves, Nicholas ; Kularatna, Sanjeewa ; Barnett, Adrian. In: Health Economics Review. RePEc:spr:hecrev:v:11:y:2021:i:1:d:10.1186_s13561-021-00312-4.

Full description at Econpapers || Download paper

2021State of the ART? Two New Tools for Risk Communication in Health Technology Assessments. (2021). Grutters, Janneke ; Otten, Thomas ; Wijnen, Ben ; Pouwels, Xavier ; Grimm, Sabine E ; Joore, Manuela A. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:10:d:10.1007_s40273-021-01060-3.

Full description at Econpapers || Download paper

2021Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective. (2021). Patel, Dipen ; Diakite, Ibrahim ; Liu, Rongzhe ; Briggs, Andrew ; Djatche, Laurence M ; Alsumali, Adnan ; Lautsch, Dominik ; Wang, Yufei. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:11:d:10.1007_s40273-021-01091-w.

Full description at Econpapers || Download paper

2021Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review. (2021). , Antoinette ; Villar, Fernando Antoanzas ; Postma, Maarten J ; Garcia, Paula Rojas ; van der Pol, Simon. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:12:d:10.1007_s40273-021-01054-1.

Full description at Econpapers || Download paper

2021A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper. (2021). Strong, Mark ; Seo, Mikyung Kelly. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:12:d:10.1007_s40273-021-01069-8.

Full description at Econpapers || Download paper

2021Quantitative Evidence Synthesis Methods for the Assessment of the Effectiveness of Treatment Sequences for Clinical and Economic Decision Making: A Review and Taxonomy of Simplifying Assumptions. (2021). Wilkinson, Clare ; Sutton, Alex J ; Hughes, Dyfrig ; Lewis, Ruth A. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:1:d:10.1007_s40273-020-00980-w.

Full description at Econpapers || Download paper

2021Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier. (2021). Paulden, Mike ; Hall, Peter ; Sutton, Andrew ; Tramonti, Giovanni ; McCabe, Christopher. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:1:d:10.1007_s40273-020-00983-7.

Full description at Econpapers || Download paper

2021Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve. (2021). Sendi, Pedram. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00969-5.

Full description at Econpapers || Download paper

2021Modifying NICE’s Approach to Equity Weighting. (2021). McCabe, Christopher ; Paulden, Mike. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00988-2.

Full description at Econpapers || Download paper

2021NICE’s Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial Interests. (2021). Paulden, Mike ; Omahony, James F ; McCabe, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00990-8.

Full description at Econpapers || Download paper

2021Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). (2021). Bousmah, Marwân-al-Qays ; Varloteaux, Marie ; Bassega, Pierrette Omgba ; Maradan, Gwenaelle ; Mpoudi-Etame, Mireille ; Wandji, Martial Lantche ; Tovar-Sanchez, Tamara ; Nishimwe, Marie Liberee ; Boyer, Sylvie ; Marwan-Al-Qays Bousmah, ; Delaporte, Eric ; Kouanfack, Charles ; Montoyo, Alice. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:3:d:10.1007_s40273-020-00987-3.

Full description at Econpapers || Download 2021

The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States. (2021). Kumar, Princy N ; La, Elizabeth M ; Davis, Ashley E ; Talbird, Sandra E ; Brogan, Anita J. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-020-00992-6.

Full description at Econpapers || Download paper

2021Macrovascular Risk Equations Based on the CANVAS Program. (2021). Neslusan, Cheryl ; Nilsson, Andreas ; Slee, April ; Asseburg, Christian ; Willis, Michael. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-021-01001-0.

Full description at Econpapers || Download paper

2021Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals. (2021). Latimer, Nicholas R ; Srivastava, Tushar ; Tappenden, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:8:d:10.1007_s40273-021-01034-5.

Full description at Econpapers || Download paper

2022In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era. (2022). Exel, Job ; Roijen, Leona Hakkaart-Van ; Kanters, Tim ; Sajjad, Ayesha ; Huls, Samare ; Brouwer, Werner. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:1:d:10.1007_s40273-021-01117-3.

Full description at Econpapers || Download paper

2022Factors Limiting Subgroup Analysis in Cost-Effectiveness Analysis and a Call for Transparency. (2022). Davies, Linda M ; Verma, Arpana ; Farragher, Tracey ; Clarkson, Paul ; Wilberforce, Mark ; Shields, Gemma E. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-021-01108-4.

Full description at Econpapers || Download paper

2022Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the Unit. (2022). Jokubaitis, Vilija G ; Lechner-Scott, Jeannette ; Havrdova, Eva ; Walt, Anneke ; Granella, Franco ; Hyde, Robert ; Oreja-Guevara, Celia ; Pucci, Eugenio ; Dort, Thibaut ; Pesch, Vincent ; Alroughani, Raed ; Acosta, Carlos ; Hupperts, Raymond ; Duquette, Pierre ; Freudensprung, Ulrich ; Boz, Cavit ; Grammond, Pierre ; Pearson, Isobel ; Rozsa, Csilla ; Izquierdo, Guillermo ; Tempest, Michael ; Terzi, Murat ; Lugaresi, Alessandra ; Zhang, Yuanhui ; Grandmaison, Francois ; Luca, Giovanna ; Herring, William L ; Butzkueven, Helmut ; Ferraro, Diana ; Trojano, Maria ; Spel
2022Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time. (2022). Elvidge, Jamie ; Wright, Stuart ; Bullement, Ash ; Pennington, Becky ; Shields, Gemma E. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:3:d:10.1007_s40273-021-01116-4.

Full description at Econpapers || Download paper

2022Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US. (2022). Alsumali, Adnan ; Goswami, Hardik ; Puenpatom, Amy ; Briggs, Andrew ; Cohen, Joshua ; Duke, Elizabeth R ; Schindler, Matthias ; Jiang, Yiling. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:7:d:10.1007_s40273-022-01168-0.

Full description at Econpapers || Download paper

2021Minimally Invasive Sacroiliac Joint Fusion with Triangular Titanium Implants: Cost-Utility Analysis from NHS Perspective. (2021). Newton, Matthew P ; Blissett, Rob S ; Reckling, Carlton W ; Cher, Daniel J ; Stott, Philip M. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:2:d:10.1007_s41669-020-00236-5.

Full description at Econpapers || Download paper

2021Introducing Rotavirus Vaccination in Nigeria: Economic Evaluation and Implications. (2021). Okafor, Charles Ebuka. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-020-00251-6.

Full description at Econpapers || Download paper

2021Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology. (2021). Levine, Mitch ; Ball, Graeme ; Tarride, Jean-Eric ; Thabane, Lehana. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-021-00263-w.

Full description at Econpapers || Download paper

2021Breathing Synchronised Hypoglossal Nerve Stimulation with Inspire for Untreated Severe Obstructive Sleep Apnoea/Hypopnoea Syndrome: A Simulated Cost-Utility Analysis from a National Health Service Per. (2021). Steier, Joerg S ; Blissett, Deirdre B ; Karagama, Yakubu G. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-021-00266-7.

Full description at Econpapers || Download paper

2022Cost-Effectiveness Analysis of the Treatment Strategies with or without Opioid Medications in Surgery-Eligible Patients with Osteoarthritis in Japan. (2022). Ishijima, Muneaki ; Fujii, Koichi ; Ebata, Nozomi ; Matsuda, Hiroyuki ; Demiya, Sven ; Yonemoto, Naohiro ; Yuasa, Akira ; Takura, Tomoyuki . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:1:d:10.1007_s41669-021-00292-5.

Full description at Econpapers || Download paper

2022Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada. (2022). Lukyanov, Vasily ; Fenu, Elisabetta ; Oppe, Mark ; Marshall, John K ; Fischer, Aren ; Stypa, Stephanie ; Radu, Xenia ; Acs, Annabel. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:4:d:10.1007_s41669-022-00331-9.

Full description at Econpapers || Download paper

2021Value of Life Year and Cost-Effectiveness Thresholds: The Case of Poland. (2021). Olimpia, Markiewicz. In: Central European Economic Journal. RePEc:vrs:ceuecj:v:8:y:2021:i:55:p:256-268:n:14.

Full description at Econpapers || Download paper

2021The economic costs of child maltreatment in UK. (2021). Conti, Gabriella ; Melnychuk, Mariya ; Morris, Stephen ; Pizzo, Elena. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:12:p:3087-3105.

Full description at Econpapers || Download paper

2021Cost?effectiveness analysis of public health interventions with impacts on health and criminal justice: An applied cross?sectoral analysis of an alcohol misuse intervention. (2021). Richardson, Gerry ; Kanaan, Mona ; Coulton, Simon ; Deluca, Paolo ; Drummond, Colin ; Parrott, Steve ; Griffin, Susan ; Walker, Simon ; Ramponi, Francesco. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:5:p:972-988.

Full description at Econpapers || Download paper

2021Estimating optimal willingness to pay thresholds for cost?effectiveness analysis: A generalized method. (2021). Cinatl, Chris ; Phelps, Charles E. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:7:p:1697-1702.

Full description at Econpapers || Download paper

2021The value of health—Empirical issues when estimating the monetary value of a quality?adjusted life year based on well?being data. (2021). , Werner ; van Exel, Job ; Stockel, Jannis ; Himmler, Sebastian. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:8:p:1849-1870.

Full description at Econpapers || Download paper

2021Early childhood education and life?cycle health. (2021). Heckman, James ; Garcia, Jorge Luis. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:s1:p:119-141.

Full description at Econpapers || Download paper

Works by Mark Sculpher:


YearTitleTypeCited
2015Country-level cost-effectiveness thresholds: initial estimates and the need for further research In: Working Papers.
[Full Text][Citation analysis]
paper50
2016Supporting the development of an essential health package: principles and initial assessment for Malawi In: Working Papers.
[Full Text][Citation analysis]
paper3
2017Scoping review on social care economic evaluation methods In: Working Papers.
[Full Text][Citation analysis]
paper0
1999A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis In: Working Papers.
[Full Text][Citation analysis]
paper0
2000Improving the efficiency and relevance of health technology assessent: the role of iterative decision analytic modelling In: Working Papers.
[Full Text][Citation analysis]
paper7
2007Mark versus Luke? Appropriate Methods for the Evaluation of Public Health Interventions In: Working Papers.
[Full Text][Citation analysis]
paper10
2010Appropriate Perspectives for Health Care Decisions In: Working Papers.
[Full Text][Citation analysis]
paper43
2005The value of implementation and the value of information: combined and uneven development In: Working Papers.
[Full Text][Citation analysis]
paper3
2011Value-based pricing for pharmaceuticals: Its role, specification and prospects in a newly devolved NHS In: Working Papers.
[Full Text][Citation analysis]
paper10
2012Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions In: Working Papers.
[Full Text][Citation analysis]
paper22
2013Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers.
[Full Text][Citation analysis]
paper51
2014Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: Are current international norms fit for purpose? In: Working Papers.
[Full Text][Citation analysis]
paper7
2006Defining and characterising structural uncertainty in decision analytic models In: Working Papers.
[Full Text][Citation analysis]
paper6
2009Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations In: Health Policy.
[Full Text][Citation analysis]
article29
2002Shared treatment decision making in a collectively funded health care system: possible conflicts and some potential solutions In: Social Science & Medicine.
[Full Text][Citation analysis]
article4
2012Decision-making with Uncertainty: The Value of Information In: Chapters.
[Full Text][Citation analysis]
chapter0
2006Decision-making with Uncertainty: The Value of Information.(2006) In: Chapters.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
chapter
1999Recognizing Preference Diversity: The Use of Preference Sub-Groups in Cost-Effectiveness Analysis In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]
paper0
1999Income Effects of Reduced Health and Health Effects of Reduced Income: Implications for Health State Valuation In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]
paper0
1999Building Uncertainty into Cost-Effectiveness Rankings: Portfolio Risk-Return Trade-Offs and Implications for Decision Rules In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]
paper0
2000Productivity Costs: Principles and Practice in Economic Evaluation In: Monographs.
[Full Text][Citation analysis]
book12
2006Decision Modelling for Health Economic Evaluation In: OUP Catalogue.
[Citation analysis]
book334
2014What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2010An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2005Estimating utility data from clinical indicators for patients with stable angina In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article6
2000Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2006Assessing Generalisability in Model-Based Economic Evaluation Studies In: PharmacoEconomics.
[Full Text][Citation analysis]
article2
2007A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2007Recombinant Erythropoietin for Chemotherapy-Related Anaemia In: PharmacoEconomics.
[Full Text][Citation analysis]
article3
2012Real Economics Needs to Reflect Real Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]
article2
2012Golimumab for the Treatment of Psoriatic Arthritis In: PharmacoEconomics.
[Full Text][Citation analysis]
article26
2013Acknowledging Patient Heterogeneity in Economic Evaluation In: PharmacoEconomics.
[Full Text][Citation analysis]
article2
2016Should the Lambda (?) Remain Silent? In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2001Recognizing diversity in public preferences: The use of preference sub?groups in cost?effectiveness analysis In: Health Economics.
[Full Text][Citation analysis]
article15
2001Representing uncertainty: the role of cost?effectiveness acceptability curves In: Health Economics.
[Full Text][Citation analysis]
article77
2002Recognising diversity in public preferences: the use of preference sub?groups in cost?effectiveness analysis. Authors reply In: Health Economics.
[Full Text][Citation analysis]
article0
2005Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra In: Health Economics.
[Full Text][Citation analysis]
article64
2005Assessing generalisability by location in trial?based cost?effectiveness analysis: the use of multilevel models In: Health Economics.
[Full Text][Citation analysis]
article19
2005Estimating mean QALYs in trial?based cost?effectiveness analysis: the importance of controlling for baseline utility In: Health Economics.
[Full Text][Citation analysis]
article32
2006Discounting and cost?effectiveness in NICE – stepping back to sort out a confusion In: Health Economics.
[Full Text][Citation analysis]
article18
2006Evidence synthesis, parameter correlation and probabilistic sensitivity analysis In: Health Economics.
[Full Text][Citation analysis]
article8
2006Whither trial?based economic evaluation for health care decision making? In: Health Economics.
[Full Text][Citation analysis]
article38
2010Sins of omission and obfuscation: IQWIGs guidelines on economic evaluation methods In: Health Economics.
[Full Text][Citation analysis]
article2
2011Dangerous omissions: the consequences of ignoring decision uncertainty In: Health Economics.
[Full Text][Citation analysis]
article12
2015CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? In: Health Economics.
[Full Text][Citation analysis]
article16
2018Social value and individual choice: The value of a choice?based decision?making process in a collectively funded health system In: Health Economics.
[Full Text][Citation analysis]
article0
2018How to design the cost?effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework In: Health Economics.
[Full Text][Citation analysis]
article1
1995Sensitivity analysis in economic evaluation: A review of published studies In: Health Economics.
[Full Text][Citation analysis]
article10
1998The cost?effectiveness of preference?based treatment allocation: the case of hysterectomy versus endometrial resection in the treatment of menorrhagia In: Health Economics.
[Full Text][Citation analysis]
article1
1995Economic Evaluation in Health Care Research and Development: Undertake it Early and Often In: Discussion Papers.
[Full Text][Citation analysis]
paper0
1996Antenatal testing for HIV Infection: Developing a Model for Economic Evaluation In: Discussion Papers.
[Full Text][Citation analysis]
paper0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated August, 1st 2022. Contact: CitEc Team